Clinical Pharmacology and Therapeutics - Table of Contents alert Volume 94 Issue 6

TABLE OF CONTENTS Volume 94, Issue 6 (December 2013) In this issue In This Issue Editorial News & Views Perspectives Discovery & Development CPIC Guidelines State of the Art Review Research Also new AOP Sign up for CPT: Pharmacometrics & Systems Pharmacology e-alerts Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Emerging therapeutic targets for T2DM  Type 2 diabetes mellitus (T2DM) is one of the most prevalent noncommunicable diseases in the world. New therapeutic targets for T2DM have been uncovered in the past decade, some of which have reached clinical application. This Nature Reviews Endocrinology collection gives an overview of the emerging therapeutic targets for T2DM, discussing promising avenues uncovered from basic, translational and clinical research.   The collection is free for 6 months thanks to support from   In This Issue Top In This Issue Clin Pharmacol Ther 2013 94: 611; 10.1038/clpt.2013.199 Full Text Editorial Top Network Medicine: Finding the Links to Personalized Therapy J Y Chen, M Piquette-Miller and B P Smith Clin Pharmacol Ther 2013 94: 613-616; 10.1038/clpt.2013.195 Abstract | Full Text News & Views Top HIGHLIGHTS Clin Pharmacol Ther 2013 94: 618-619; 10.1038/clpt.2013.198 Full Text ASCPT NEWS Clin Pharmacol Ther 2013 94: 620-623; 10.1038/clpt.2013.189 Full Text BOOKS Regenerative Pharmacology Reviewed by  G M Ellison Clin Pharmacol Ther 2013 94: 624-625; 10.1038/clpt.2013.160 Full Text Perspectives Top COMMENTARIES Network Medicine in Disease Analysis and Therapeutics B Chen and A J Butte Clin Pharmacol Ther 2013 94: 627-629; 10.1038/clpt.2013.181 Abstract | Full Text Managing the Risk of Drug-Induced Liver Injury P B Watkins Clin Pharmacol Ther 2013 94: 629-631; 10.1038/clpt.2013.182 Abstract | Full Text Challenges in Interpreting the Evidence for Genetic Predictors of Ototoxicity M J Ratain, N J Cox and T O Henderson Clin Pharmacol Ther 2013 94: 631-635; 10.1038/clpt.2013.178 Abstract | Full Text Discovery & Development Top DISCOVERY Profiling Solute Carrier Transporters in the Human Blood–Brain Barrier E G Geier, E C Chen, A Webb, A C Papp, S W Yee, W Sadee and K M Giacomini Clin Pharmacol Ther 2013 94: 636-639; advance online publication, September 5, 2013; 10.1038/clpt.2013.175 Abstract | Full Text CPIC Guidelines Top Clinical Pharmacogenetics Implementation Consortium Guidelines for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing K E Caudle, C F Thorn, T E Klein, J J Swen, H L McLeod, R B Diasio and M Schwab Clin Pharmacol Ther 2013 94: 640-645; advance online publication, August 29, 2013; 10.1038/clpt.2013.172 Abstract | Full Text State of the Art Top Personalized Network-Based Treatments in Oncology X Robin, P Creixell, O Radetskaya, CC  Santini, J Longden and R Linding Clin Pharmacol Ther 2013 94: 646-650; advance online publication, August 29, 2013; 10.1038/clpt.2013.171 Abstract | Full Text Network-Based Approaches in Drug Discovery and Early Development J M Harrold, M Ramanathan and D E Mager Clin Pharmacol Ther 2013 94: 651-658; advance online publication, September 11, 2013; 10.1038/clpt.2013.176 Abstract | Full Text Connecting the Dots: Applications of Network Medicine in Pharmacology and Disease A Jacunski and N P Tatonetti Clin Pharmacol Ther 2013 94: 659-669; advance online publication, August 29, 2013; 10.1038/clpt.2013.168 Abstract | Full Text Review Top Clinical and Regulatory Features of Drugs Not Initially Approved by the FDA B Wang, J Avorn and A S Kesselheim Clin Pharmacol Ther 2013 94: 670-677; advance online publication, August 20, 2013; 10.1038/clpt.2013.165 Abstract | Full Text Research Top Association of CYP2C9*2 With Bosentan-Induced Liver Injury S M Markova, T De Marco, N Bendjilali, E A Kobashigawa, J Mefford, J Sodhi, H Le, C Zhang, J Halladay, A E Rettie, C Khojasteh, D McGlothlin, A H B Wu, W-C Hsueh, J S Witte, J B Schwartz and D L Kroetz Clin Pharmacol Ther 2013 94: 678-686; advance online publication, July 17, 2013; 10.1038/clpt.2013.143 Abstract | Full Text Genetic and Pharmacokinetic Determinants of Response to Transdermal Nicotine in White, Black, and Asian Nonsmokers D A Dempsey, G St.Helen, P Jacob, III, R F Tyndale and N L Benowitz Clin Pharmacol Ther 2013 94: 687-694; advance online publication, August 9, 2013; 10.1038/clpt.2013.159 Abstract | Full Text SLCO1B1 Genetic Variant Associated With Statin-Induced Myopathy: A Proof-of-Concept Study Using the Clinical Practice Research Datalink OPEN D F Carr, H O’Meara, A L Jorgensen, J Campbell, M Hobbs, G McCann, T van Staa and M Pirmohamed Clin Pharmacol Ther 2013 94: 695-701; advance online publication, August 13, 2013; 10.1038/clpt.2013.161 Abstract | Full Text ARTICLES Chronological Effects of Rifampicin Discontinuation on Cytochrome P450 Activity in Healthy Japanese Volunteers, Using the Cocktail Method N Inui, T Akamatsu, S Uchida, S Tanaka, N Namiki, M Karayama, K Chida and H Watanabe Clin Pharmacol Ther 2013 94: 702-708; advance online publication, August 23, 2013; 10.1038/clpt.2013.167 Abstract | Full Text Advertisement   New content available each week! Original Research - Reviews & Perspectives - Tutorials CPT: PSP publishes critical content covering the latest advances in quantitative methods as applied in pharmacology, physiology, and therapeutics in humans with a common focus on the application of these two areas on drug development. CPT: PSP is an online open access journal.      Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Clinical Pharmacology & Therapeutics. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.